Wilson Sonsini
Wilson Sonsini is a leading law firm with a deep history representing trailblazers across the life sciences industry — from early-stage innovators to companies shaping the future of healthcare. The firm’s life sciences practice supports biopharmaceutical companies across the full business lifecycle, from formation and IP strategy through IPO, M&A, and strategic collaborations. Wilson Sonsini frequently serves as outside general counsel, drawing on a cross-functional global team that includes over 100 attorneys and advisors with Ph.D.s, former in-house counsel, and alumni of the USPTO and PTAB. The firm has advised 1,800+ private and 170+ publicly traded life sciences companies, completed transactions valued at more than $122.5 billion between 2020–2025, and raised over $38 billion across 1,500+ venture rounds.
